Nektar Therapeutics (NKTR) — Cash Flow Quality Index
Nektar Therapeutics (NKTR) has a Cash Flow Quality Index of -6.36x as of December 2024. Operating cash flow of $-46.19 Million is below net income of $7.26 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how well can Nektar Therapeutics service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Nektar Therapeutics Cash Flow Quality Index (2018–2018)
Historical Cash Flow Quality Index for Nektar Therapeutics across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Nektar Therapeutics cash flow conversion.
Annual Cash Flow Quality Index for Nektar Therapeutics (2018–2018)
Year-by-year earnings quality comparison for Nektar Therapeutics.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2018 | 1.05x | $718.21 Million | $681.31 Million | — |